Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Antiviral activity against EBV infected in Mononuclear cell assessed as viral growth inhibition incubated for 25 hrs by microscopic analysis
Assay data:1 Tested
SummaryPubMed Citation
Antiviral activity against EBV infected in P3HR1 cells assessed as decrease in viral replication
Assay data:6 Active, 1 Activity ≤ 1 µM, 6 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed Citation
Antiviral activity against EBV infected in P3HR1 cells assessed as decrease in Rta cells at 10 uM measured after 24 hrs by Western blot analysis relative to control
Assay data:9 Tested
Antiviral activity against Epstein-Barr virus infected in human Akata cells
Assay data:3 Tested
Chemopreventive activity in human Raji cells assessed as molar ratio of compound required to inhibit 50% of control of inhibition of TPA-induced EBV-early antigen activation after 48 hrs by immunofluorescence analysis
Assay data:13 Tested
Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as EA activation after 48 hrs
Assay data:23 Tested
Inhibition of TPA-induced EBV early antigen activation in human Raji cells relative to TPA
Assay data:12 Tested
Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as EA activation
Assay data:5 Tested
Inhibition of TPA-induced EBV-early antigen activation in human Raji cells relative to TPA
Assay data:16 Tested
Inhibition of TPA-induced EBV-early antigen activation in human Raji cells
Assay data:15 Tested
Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as EA induction after 48 hrs relative to TPA
Assay data:20 Tested
Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells assessed as EA activation per 32 pmol TPA after 48 hrs
Assay data:6 Tested
Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells assessed per 32 pmol TPA
Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells assessed per 32 pmol TPA by immunofluorescence technique
Assay data:17 Tested
Inhibition of TPA-induced EBV-early antigen activation in human Raji cells per 32 pmol TPA after 48 hrs
Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as early antigen activation after 48 hrs relative to control
Inhibition of EBV replication in H1 cells by DNA hybridization assay
Assay data:1 Active, 9 Tested
SummaryCompounds, ActivePubMed Citation
Reduction in the number of Epstein barr virus genome copies in P3HR-1 infected cells was determined
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Inhibition of epstein barr virus(EBV) by nucleic acid hybridization assay in human lung fibroblast cell line; Stimulated EBV induction by 70% at 50 uM
Inhibition of epstein barr virus(EBV) by nucleic acid hybridization assay in human lung fibroblast cell line; Stimulated EBV induction by 70 at 50 uM
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on